← 返回

祖细胞耗竭 T 细胞作为食管鳞状细胞癌的预后指标:揭示其对肿瘤免疫的关键贡献

英文原题:Progenitor-exhausted T cell as prognostic indicator in esophageal squamous cell carcinoma: illuminating their key contribution to tumor immunity.

查看英文原题

Progenitor-exhausted T cell as prognostic indicator in esophageal squamous cell carcinoma: illuminating their key contribution to tumor immunity.

PubMed 2025/09/26(内容时间) Front Immunol Q1 · IF 7(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

研究概要

我们的研究结果确定了 T pex 细胞是 ESCC 中一个关键的预后和免疫活性 CD8⁺T 细胞亚群。

中文摘要

尽管免疫检查点抑制剂(ICI)治疗食管鳞状细胞癌(ESCC)已取得显著进展,其临床疗效仍有限,主要原因是CD8⁺ T细胞耗竭。祖细胞耗竭型T细胞(Tpex)是其中一个关键亚群,具有干细胞样特征,可维持持久的抗肿瘤免疫。

研究采用多重免疫组化(mIHC)确定Tpex细胞在ESCC肿瘤微环境(TME)中的空间分布及临床意义,并进一步分析公开的单细胞RNA测序(scRNA-seq)数据,以表征Tpex细胞表型、分化轨迹和细胞间通讯网络。

Tpex细胞构成浸润性CD8⁺ T细胞中的一个独特亚群,并代表耗竭连续谱上的一个过渡阶段。ESCC患者Tpex浸润程度较高与总生存期改善显著相关。此外,接受PD-1阻断治疗患者的scRNA-seq数据表明,应答者的Tpex群体明显多于未应答者。

本研究确定Tpex细胞是ESCC中具有关键预后价值和免疫活性的CD8⁺ T细胞亚群。其丰度和功能参与程度与良好临床结局及PD-1阻断应答密切相关。Tpex的干细胞样特性可能对形成持久抗肿瘤免疫至关重要,并可为增强PD-1免疫治疗疗效提供新的治疗靶点。

展开英文摘要原文

Despite notable advances with immune checkpoint inhibitors (ICIs) in esophageal squamous cell carcinoma (ESCC), their clinical efficacy remains limited, largely due to CD8⁺T cell exhaustion. Among these, progenitor exhausted T cells (T pex ) represent a key subset with stem cell-like features that sustain durable anti-tumor immunity.

We applied multi-color immunohistochemistry (mIHC) to determine the spatial distribution and clinical significance of T pex cells within the tumor microenvironment (TME) of ESCC. Publicly available single-cell RNA sequencing (scRNA-seq) datasets were further analyzed to characterize T pex cell phenotypes, differentiation trajectories, and intercellular communication networks.

T pex cells constituted a distinct subset of infiltrating CD8⁺T cells and represented a transitional stage of the exhaustion continuum. A higher degree of T pex infiltration was significantly associated with improved overall survival in ESCC patients. Moreover, scRNA-seq data from patients treated with PD-1 blockade revealed that responders harbored markedly enriched T pex populations compared with non-responders.

Our findings identify T pex cells as a critical prognostic and immunologically active CD8⁺T cell subset in ESCC. Their abundance and functional engagement are closely associated with favorable clinical outcomes and response to PD-1 blockade. Furthermore, their stem cell-like properties may be pivotal in shaping durable anti-tumor immunity and could provide novel therapeutic targets to enhance the efficacy of PD-1-based immunotherapy.

论文信息

作者
Liu Y、Jiang H、Fang Z、Xu B、Chen J、Zheng X、Geng R、Chen L
单位
Department of Tumor Biological Treatment, The Third Affiliated Hospital of Soochow University, Changzhou, Jiangsu, China.China
期刊
Frontiers in immunology2025
原文标识
PubMed 41080578 · DOI 10.3389/fimmu.2025.1659077